Ariad Pharmaceuticals, Inc. Expands Leadership Team with Three New Appointments, 2 VPs and Senior Medical Director

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of three senior executives to newly created positions on ARIAD’s leadership team: Matthew E. Ros as vice president, oncology marketing, Virginia R. Dean as vice president, human resources, and Frank G. Haluska, M.D., Ph.D. as senior medical director.
MORE ON THIS TOPIC